Affordable Access

Publisher Website

Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.

Authors
Type
Published Article
Journal
Calcified tissue international
Publication Date
Volume
86
Issue
2
Pages
132–141
Identifiers
DOI: 10.1007/s00223-009-9327-6
PMID: 20049422
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments